Eurofins Scientific SE (ERFSF)
OTC: ERFSF
· Real-Time Price · USD
80.19
2.19 (2.81%)
At close: Aug 19, 2025, 11:49 AM
Eurofins Scientific SE Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 613.9M | 681.2M | 749.1M | 686.4M | 486.6M | 718.8M | 515.3M | 639.9M |
Short-Term Investments | n/a | n/a | 472.1M | -53M | 54.4M | -57.1M | 17.4M | -41.3M |
Long-Term Investments | n/a | 84.8M | 83.6M | 80.4M | 83.6M | 82.7M | 81.7M | 61.5M |
Other Long-Term Assets | 117.4M | n/a | n/a | n/a | 100K | n/a | n/a | n/a |
Receivables | 1.51B | 1.42B | 1.38B | 1.36B | 1.34B | 1.47B | 1.39B | 1.32B |
Inventory | 141.9M | 142.4M | 139M | 150.3M | 145.6M | 159.2M | 154.2M | 169.1M |
Other Current Assets | 103.6M | 120.9M | 236.5M | 154.3M | 255.5M | 125.5M | 191.8M | 89.5M |
Total Current Assets | 2.45B | 2.61B | 3.07B | 2.58B | 2.31B | 2.71B | 2.32B | 2.41B |
Property-Plant & Equipment | 2.56B | 2.44B | 2.3B | 2.21B | 2.17B | 1.98B | 1.83B | 1.67B |
Goodwill & Intangibles | 5.63B | 5.55B | 5.35B | 5.37B | 5.44B | 5.42B | 5.01B | 4.46B |
Total Long-Term Assets | 8.44B | 8.18B | 7.82B | 7.73B | 7.77B | 7.55B | 7.01B | 6.25B |
Total Assets | 10.89B | 10.8B | 10.89B | 10.32B | 10.08B | 10.26B | 9.33B | 8.66B |
Account Payables | 645.9M | 588.8M | 339.2M | 564.8M | 347.4M | 590.3M | 322.9M | 530.8M |
Deferred Revenue | n/a | -100K | 192.8M | 1.09B | 184.2M | 249.3M | 974.4M | 1.1B |
Short-Term Debt | 328.6M | 23.3M | 458.4M | 13.7M | 85.2M | 132.7M | 133.1M | 128.2M |
Other Current Liabilities | 228.6M | 970M | 358.2M | 1.01B | 375M | 891.9M | 418.7M | 1.05B |
Total Current Liabilities | 2.11B | 1.84B | 2.12B | 1.8B | 1.77B | 2.03B | 1.86B | 1.76B |
Long-Term Debt | 2.67B | 2.91B | 3.89B | 2.72B | 2.71B | 2.69B | 2.08B | 2.53B |
Other Long-Term Liabilities | 152.4M | 284.9M | 193.8M | 128.9M | 348.5M | 376.9M | 299.2M | -269.5M |
Total Long-Term Liabilities | 3.39B | 3.66B | 4.63B | 3.45B | 3.46B | 3.46B | 2.8B | 2.79B |
Total Liabilities | 5.5B | 5.5B | 6.75B | 5.25B | 5.23B | 5.49B | 4.66B | 4.55B |
Total Debt | 3.61B | 3.54B | 4.93B | 3.27B | 3.33B | 3.35B | 2.75B | 2.65B |
Common Stock | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M |
Retained Earnings | 2.69B | 2.5B | 2.39B | 2.26B | 2.33B | 2.03B | 1.96B | 1.58B |
Comprehensive Income | n/a | n/a | 1.74B | 1.79B | 1.88B | 1.99B | 1.68B | 1.5B |
Shareholders Equity | 5.34B | 5.24B | 4.08B | 5B | 4.78B | 4.7B | 4.65B | 4.08B |
Total Investments | 117.4M | 84.8M | 555.7M | 27.4M | 83.7M | 25.6M | 81.7M | 20.2M |